Calcineurin inhibitors and nephrotoxicity in children.

scientific article

Calcineurin inhibitors and nephrotoxicity in children. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12519-018-0125-Y
P698PubMed publication ID29532435

P2093author name stringJian-Hua Mao
Fei Liu
P2860cites workA receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomeraseQ24296311
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilinQ24338951
The cyclophilinsQ24812580
Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A ReviewQ26827717
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and JunQ28263918
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteinsQ29618460
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationQ29620223
Tacrolimus-associated hemolytic uremic syndrome: a case analysis.Q33358357
De novo thrombotic microangiopathy. An underrated complication of renal transplantationQ33375722
Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantationQ33378678
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure.Q34181871
Chronic allograft nephropathy: current concepts and future directionsQ34501818
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in childrenQ34659232
Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstructionQ34755789
Calcineurin inhibitor nephrotoxicityQ34945314
Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.Q35085117
Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides.Q35647093
Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndromeQ36153584
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.Q36788871
Experience with tacrolimus in children with steroid-resistant nephrotic syndromeQ37229944
Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejectionQ37320783
Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?Q37821472
Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidenceQ38116657
Is it time to give up with calcineurin inhibitors in kidney transplantation?Q38156847
Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.Q38569641
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitorsQ38630386
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus ErasQ39680835
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein responseQ39849371
Response of human renal tubular cells to cyclosporine and sirolimus: a toxicogenomic studyQ40115041
Banff 07 classification of renal allograft pathology: updates and future directionsQ40121163
A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsiesQ40182802
Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging TechniqueQ40338749
Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus NephrotoxicityQ40709714
Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndromeQ40775615
Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapyQ41184484
Second-line options for refractory steroid-sensitive and -resistant nephrotic syndromeQ42723614
Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathyQ43687552
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicityQ44213050
Renal interstitial fibrosis in children treated with FK506 for nephrotic syndromeQ44853317
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression.Q44900413
Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantationQ46531742
Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft functionQ46908569
Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsiesQ46935290
Sirolimus in chronic allograft nephropathy in pediatric recipientsQ46970910
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin AQ46979889
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children.Q50905464
Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula.Q51292313
Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity.Q52970451
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children.Q53360030
Effect of cyclosporine administration on renal hemodynamics in conscious rats.Q54441851
Maintenance Immunosuppression With Mycophenolate Mofetil and Corticosteroids in Pediatric Kidney Transplantation: Temporary Benefit but Not Without RiskQ59564426
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal GraftsQ61859683
Safety and Efficacy of a Calcineurin Inhibitor Avoidance Regimen in Pediatric Renal TransplantationQ63244404
Glomerulotubular function in cyclosporine-treated rats. A lithium clearance, occlusion time/transit time and micropuncture studyQ70096014
Cyclosporine-associated chronic nephropathyQ70376376
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathyQ73683739
The side-effects of ciclosporine-A and tacrolimusQ77059728
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study GroupQ77781312
Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejectionQ78106839
Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimusQ79422909
SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicityQ79953119
Early experience with conversion to sirolimus in a pediatric renal transplant populationQ80727373
Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathyQ83377108
Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndromeQ84415164
Histological characteristics of calcineurin inhibitor toxicity--there is no such thing as specificity!Q84870341
Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney diseaseQ86731520
P433issue2
P304page(s)121-126
P577publication date2018-03-12
P1433published inWorld Journal of PediatricsQ15763275
P1476titleCalcineurin inhibitors and nephrotoxicity in children.
P478volume14

Reverse relations

Q55515010Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.cites workP2860

Search more.